• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生儿早老综合征患者的体脂分布和代谢变量

Body fat distribution and metabolic variables in patients with neonatal progeroid syndrome.

作者信息

O'Neill Brendan, Simha Vinaya, Kotha Vani, Garg Abhimanyu

机构信息

Division of Nutrition and Metabolic Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.

出版信息

Am J Med Genet A. 2007 Jul 1;143A(13):1421-30. doi: 10.1002/ajmg.a.31840.

DOI:10.1002/ajmg.a.31840
PMID:17523150
Abstract

Neonatal progeroid syndrome (NPS), also known as Wiedemann-Rautenstrauch Syndrome, is a rare autosomal recessive disorder characterized by accelerated aging and lipodystrophy from birth. Affected children have extreme intrauterine growth retardation, poor postnatal weight gain, and characteristic facial dysmorphic features such as a triangular shape, pinched nose, pseudohydrocephalus with wide fontanelles and prominent subcutaneous (sc) veins. Generalized loss of sc fat has been reported as a cardinal feature; however, the pattern of fat loss and its association with insulin resistance and its metabolic complications have not been systematically studied. The aim of the current study was to examine body fat distribution and body composition in two girls with NPS using anthropometric measures, whole-body magnetic resonance imaging (MRI) and dual energy X-ray absorptiometry (DEXA), and to assess metabolic complications such as hyperinsulinemia and dyslipidemia. Both the girls (aged 17 years and 10 years, respectively) had generalized paucity of sc fat on physical examination. However, measurements of skin-fold thickness revealed that sc fat was decreased over the extremities, but preserved over the chest and abdomen. MRI studies confirmed the presence of normal amounts of sc truncal fat, and marked loss of fat from the face and distal extremities. Striking fat loss was also noted in the paravertebral and lateral gluteal regions. Interestingly, body composition analysis with DEXA scan revealed a marked reduction in both the fat and lean tissue mass. Fasting glucose, lipids and insulin levels were not elevated. We conclude that patients with NPS do not have generalized lipodystrophy as previously reported, but fat loss is confined to the face, distal extremities, and possibly the paravertebral and lateral gluteal regions. Metabolic abnormalities related to insulin resistance are also uncommon in this condition.

摘要

新生儿早老综合征(NPS),也称为维德曼 - 劳滕施劳赫综合征,是一种罕见的常染色体隐性疾病,其特征是从出生起就出现加速衰老和脂肪营养不良。患病儿童有严重的宫内生长迟缓、出生后体重增加不佳,以及特征性的面部畸形特征,如三角形脸、尖鼻、囟门宽大伴假性脑积水和明显的皮下静脉。皮下脂肪普遍缺失已被报道为主要特征;然而,脂肪丢失的模式及其与胰岛素抵抗及其代谢并发症的关联尚未得到系统研究。本研究的目的是使用人体测量学方法、全身磁共振成像(MRI)和双能X线吸收法(DEXA)检查两名NPS女孩的身体脂肪分布和身体成分,并评估高胰岛素血症和血脂异常等代谢并发症。两名女孩(分别为17岁和10岁)体格检查均显示皮下脂肪普遍减少。然而,皮褶厚度测量显示四肢皮下脂肪减少,但胸部和腹部皮下脂肪保留。MRI研究证实躯干皮下脂肪量正常,面部和远端肢体脂肪明显减少。椎旁和臀外侧区域也有明显的脂肪丢失。有趣的是,DEXA扫描的身体成分分析显示脂肪和瘦组织量均显著减少。空腹血糖、血脂和胰岛素水平未升高。我们得出结论,NPS患者并不像先前报道的那样存在全身性脂肪营养不良,而是脂肪丢失局限于面部、远端肢体,可能还有椎旁和臀外侧区域。在这种情况下,与胰岛素抵抗相关的代谢异常也不常见。

相似文献

1
Body fat distribution and metabolic variables in patients with neonatal progeroid syndrome.新生儿早老综合征患者的体脂分布和代谢变量
Am J Med Genet A. 2007 Jul 1;143A(13):1421-30. doi: 10.1002/ajmg.a.31840.
2
Marfan syndrome with neonatal progeroid syndrome-like lipodystrophy associated with a novel frameshift mutation at the 3' terminus of the FBN1-gene.马凡综合征合并新生儿早老样脂肪营养不良,与 FBN1 基因 3'末端的新型移码突变相关。
Am J Med Genet A. 2010 Nov;152A(11):2749-55. doi: 10.1002/ajmg.a.33690.
3
A Novel Generalized Lipodystrophy-Associated Progeroid Syndrome Due to Recurrent Heterozygous LMNA p.T10I Mutation.一种新型的广义脂肪营养不良相关早老综合征与 LMNA p.T10I 错义突变的反复杂合性相关。
J Clin Endocrinol Metab. 2018 Mar 1;103(3):1005-1014. doi: 10.1210/jc.2017-02078.
4
Body fat distribution and metabolic derangements in patients with familial partial lipodystrophy associated with mandibuloacral dysplasia.与下颌骨-肢端发育不良相关的家族性部分脂肪营养不良患者的体脂分布和代谢紊乱
J Clin Endocrinol Metab. 2002 Feb;87(2):776-85. doi: 10.1210/jcem.87.2.8258.
5
Phenotypic heterogeneity in body fat distribution in patients with atypical Werner's syndrome due to heterozygous Arg133Leu lamin A/C mutation.由于杂合的精氨酸133亮氨酸核纤层蛋白A/C突变导致的非典型沃纳综合征患者体脂分布的表型异质性。
J Clin Endocrinol Metab. 2005 Dec;90(12):6699-706. doi: 10.1210/jc.2005-0939. Epub 2005 Sep 20.
6
Novel subtype of congenital generalized lipodystrophy associated with muscular weakness and cervical spine instability.与肌无力和颈椎不稳相关的先天性全身脂肪营养不良新亚型。
Am J Med Genet A. 2008 Sep 15;146A(18):2318-26. doi: 10.1002/ajmg.a.32457.
7
Natural course of neonatal progeroid syndrome.新生儿类早衰综合征的自然病程。
Pediatr Neonatol. 2009 Jun;50(3):102-9. doi: 10.1016/S1875-9572(09)60044-9.
8
Bi-allelic POLR3A Loss-of-Function Variants Cause Autosomal-Recessive Wiedemann-Rautenstrauch Syndrome.POLR3A 双等位基因突变导致常染色体隐性遗传 Wiedemann-Rautenstrauch 综合征。
Am J Hum Genet. 2018 Dec 6;103(6):968-975. doi: 10.1016/j.ajhg.2018.10.010. Epub 2018 Nov 7.
9
A novel syndrome of mandibular hypoplasia, deafness, and progeroid features associated with lipodystrophy, undescended testes, and male hypogonadism.一种伴有脂肪营养不良、隐睾和男性性腺功能减退的下颌发育不良、耳聋和类早衰特征的新型综合征。
J Clin Endocrinol Metab. 2010 Oct;95(10):E192-7. doi: 10.1210/jc.2010-0419. Epub 2010 Jul 14.
10
Neonatal progeroid syndrome (Wiedemann-Rautenstrauch syndrome): report of three affected sibs.新生儿早老综合征(Wiedemann-Rautenstrauch 综合征):三例同胞受累病例报告。
Am J Med Genet A. 2011 Jul;155A(7):1712-5. doi: 10.1002/ajmg.a.34019. Epub 2011 Jun 10.

引用本文的文献

1
[Wiedemann-Rautenstrauch syndrome. The first description of a clinical case in the Russian Federation].[维德曼-劳滕施劳赫综合征。俄罗斯联邦首例临床病例描述]
Probl Endokrinol (Mosk). 2023 Oct 8;70(2):86-93. doi: 10.14341/probl13369.
2
Asprosin: its function as a novel endocrine factor in metabolic-related diseases.阿朴啡肽:作为代谢相关疾病新型内分泌因子的功能。
J Endocrinol Invest. 2024 Aug;47(8):1839-1850. doi: 10.1007/s40618-024-02360-z. Epub 2024 Apr 3.
3
Asprosin, a C-Terminal Cleavage Product of Fibrillin 1 Encoded by the Gene, in Health and Disease.
阿扑脂蛋白,一种由该基因编码的原纤蛋白1的C末端裂解产物,与健康和疾病的关系。
Mol Syndromol. 2022 May;13(3):175-183. doi: 10.1159/000520333. Epub 2022 Feb 8.
4
A pancancer overview of FBN1, asprosin and its cognate receptor OR4M1 with detailed expression profiling in ovarian cancer.FBN1、脂联素原及其同源受体OR4M1的泛癌概述以及在卵巢癌中的详细表达谱分析
Oncol Lett. 2021 Sep;22(3):650. doi: 10.3892/ol.2021.12911. Epub 2021 Jul 9.
5
Fibrillin-1 and fibrillin-1-derived asprosin in adipose tissue function and metabolic disorders.脂肪组织功能与代谢紊乱中的原纤蛋白-1及源自原纤蛋白-1的阿朴脂蛋白
J Cell Commun Signal. 2020 Jun;14(2):159-173. doi: 10.1007/s12079-020-00566-3. Epub 2020 Apr 12.
6
Energy Regulation Mechanism and Therapeutic Potential of Asprosin.胰高血糖素原样肽-3 及其受体激动剂在多囊卵巢综合征治疗中的作用
Diabetes. 2020 Apr;69(4):559-566. doi: 10.2337/dbi19-0009.
7
Increased plasma asprosin levels in patients with drug-naive anorexia nervosa.初诊神经性厌食症患者血浆脑肠肽水平升高。
Eat Weight Disord. 2021 Feb;26(1):313-321. doi: 10.1007/s40519-020-00845-3. Epub 2020 Feb 5.
8
Bi-allelic POLR3A Loss-of-Function Variants Cause Autosomal-Recessive Wiedemann-Rautenstrauch Syndrome.POLR3A 双等位基因突变导致常染色体隐性遗传 Wiedemann-Rautenstrauch 综合征。
Am J Hum Genet. 2018 Dec 6;103(6):968-975. doi: 10.1016/j.ajhg.2018.10.010. Epub 2018 Nov 7.
9
Plasma Asprosin Concentrations Are Increased in Individuals with Glucose Dysregulation and Correlated with Insulin Resistance and First-Phase Insulin Secretion.血浆 Asprosin 浓度在葡萄糖调节异常的个体中增加,并与胰岛素抵抗和第一时相胰岛素分泌相关。
Mediators Inflamm. 2018 Mar 20;2018:9471583. doi: 10.1155/2018/9471583. eCollection 2018.
10
Asprosin is a centrally acting orexigenic hormone.阿朴脂蛋白是一种中枢作用的促食欲激素。
Nat Med. 2017 Dec;23(12):1444-1453. doi: 10.1038/nm.4432. Epub 2017 Nov 6.